| 回购方案首次披露日 | 2025/4/9 | | --- | --- | | 回购方案实施期限 | 自公司第二届董事会第十二次会议通过回购方案 之日起不超过 3 个月 | | 预计回购金额 | 2,000万元~4,000万元 | | 回购用途 | □减少注册资本 □用于员工持股计划或股权激励 □用于转换公司可转债 √为维护公司价值及股东权益 | | 累计已回购股数 | 403,622股 | | 累计已回购股数占总股本比例 | 0.10% | | 累计已回购金额 | 20,027,085.97元 | | 实际回购价格区间 | 41.63元/股~53.50元/股 | 一、 回购股份的基本情况 奥比中光科技集团股份有限公司（以下简称"公司"）于 2025 年 4 月 8 日召 开第二届董事会第十二次会议，审议通过了《关于以集中竞价交易方式回购公司 股份方案的议案》，同意公司通过集中竞价交易方式回购已发行的部分人民币普通 股（A 股）股票，本次回购股份全部用于维护公司价值及股东权益，回购价格不 超过 97.00 元/股（含），回购资金总额不低于人民币 2,000 万元（含）且不超过人 民币 4,000 万元（含） ...

Core Insights - The article highlights the advancements in robotics and AI vision technology, particularly focusing on the capabilities of the robotic arm developed by Orbbec Technology, which can perform tasks with precision and flexibility through 3D vision and AI perception [1][3]. Policy and Market Drivers - The integration of machine vision and robotics is being propelled by a dual force of policy and market demand, as evidenced by the "Robot+" application action plan released by 17 government departments, which emphasizes the fusion of visual recognition technologies in various sectors [2]. - The Chinese government has set a target for the visual AI market to reach 187.3 billion RMB by 2025, indicating significant growth potential in this sector [4]. Industry Growth and Technological Development - Orbbec Technology holds over 70% market share in the 3D vision sensor field for service robots in China, showcasing its leadership in the industry [3]. - The development of 3D vision technology is characterized by its interdisciplinary nature, requiring integration across optics, mechanics, electronics, chips, and algorithms to drive breakthroughs and practical applications [4]. Financial Support and Investment - Orbbec Technology has benefited from strategic investments from various institutions, with a recent fundraising plan aiming to raise up to 2.187 billion RMB for projects related to AI vision and spatial perception technology [7]. - The article emphasizes the importance of patient capital in supporting technological innovation, particularly in high-risk fields like 3D vision technology, which often face long development cycles and substantial funding requirements [7].

Investment Rating - The investment rating for the company is "Accumulate" [8] Core Views - The company achieved a turnaround in profitability from January to May 2025, with revenue of 363 million yuan, a year-on-year increase of 117%, and a net profit attributable to shareholders of 55 million yuan, marking a return to profitability [1] - The company's strategy of "technology innovation investment - commercialization of results" is accelerating, providing a strong foundation for technological iteration and innovation across various sectors, including humanoid robots and AI hardware upgrades [1] - The humanoid robot industry is entering a rapid expansion phase, with an estimated demand of approximately 2.1 million units and a market space of about 314.6 billion yuan by 2030 [1][2] Summary by Sections Financial Performance - For the first five months of 2025, the company reported revenue of 363 million yuan and a net profit of 55 million yuan, indicating a significant recovery [1] - Revenue projections for 2025-2027 are estimated at 1.03 billion, 1.63 billion, and 2.16 billion yuan, with year-on-year growth rates of 82%, 58%, and 32% respectively [5][7] Market Position - The company is positioned in the top tier of global 3D vision technology, with a comprehensive R&D capability and a wide-ranging technology layout [3] - The demand for 3D vision sensors in humanoid robots is expected to grow from 14 million yuan in 2025 to 915 million yuan by 2030, with a CAGR of 132% [2] Product Development - The company has a strong product matrix that is widely recognized across various industries, serving over 1,000 clients including major players like Ant Group and China Mobile [3] - Continuous R&D investment has led to the development of advanced products such as the Femto series ToF cameras and Gemini series binocular structured light cameras [3] Strategic Partnerships - Ant Group has announced its entry into the humanoid robot sector, which may lead to deeper collaboration with the company in the field of robot vision sensors [4]

Investment Rating - The report does not explicitly state an overall investment rating for the industry or specific companies [2]. Core Insights - The humanoid robot industry in China is experiencing significant growth, with companies like Orbbec and Rongtai expanding their market presence and revenue projections [3][4]. - The report highlights the increasing demand for components and technologies related to humanoid robots, indicating a robust supply chain development [2][3][4][5][6][7]. Company Summaries Orbbec (688322.SS) - Orbbec's humanoid robot revenue is projected to grow from Rmb4 million in 2024 to Rmb30 million in 2025, with market share in China expected to surpass that of Intel's RealSense [3][10]. - The dollar content for 3D vision technology is anticipated to increase from Rmb4,000-5,000 to Rmb8,000 as it becomes integrated into more parts of the robot [3]. Rongtai (603119.SS) - Rongtai has a ~50% market share in micro ballscrews used in humanoid robots and is expanding its operations by building a factory in Thailand to meet US customer requirements [4][10]. - The company aims to grow its core business by 20%-30% CAGR, driven by rising penetration rates in the humanoid robot supply chain [4]. Hengli (601100.SS) - Hengli plans to reduce the production cost of planetary roller screws to ~Rmb1,000 by the end of 2025 and is considering establishing a plant in Houston, TX, to secure orders from US customers [5][10]. - The company targets a +10% YoY revenue and earnings growth, primarily driven by strong demand in the excavator component business [10]. Bozhon (688097.SS) - Bozhon's subsidiary Linkhou is expected to generate Rmb400 million-500 million in revenue in 2025 by providing components and assembly services to Zhiyuan [6][10]. - The company has sold Rmb20 million-30 million worth of humanoid robot assembly equipment to a leading US humanoid robot maker since 2024 [6]. Wolong (600580.SS) - Wolong aims to become the second electric motor supplier to Zhiyuan, targeting revenue growth from Rmb15 billion in 2024 to Rmb16 billion in 2025 [7][10]. - The company plans to pursue mergers and acquisitions to fuel long-term growth, with net profit expected to rise from Rmb793 million in 2024 to Rmb1.1 billion in 2025 [7][10].

Core Viewpoint - The report outlines the verification opinion of China International Capital Corporation regarding the listing and circulation of restricted shares from the initial public offering (IPO) of Obsidian Technology Group Co., Ltd. The restricted shares amount to 34,032,240 shares, representing 8.48% of the company's total share capital, and will be available for trading starting July 7, 2025 [1][6][10]. Summary by Sections 1. Type of Restricted Shares - The restricted shares are part of the IPO approved by the China Securities Regulatory Commission on April 22, 2022, with a total of 40,001,000 shares issued. The total share capital after the IPO is 400,001,000 shares, with 7.74% being restricted shares [1][2]. 2. Changes in Share Capital - Since the formation of the restricted shares, the company's total share capital has increased to 400,001,000 shares, with no other changes due to profit distribution or capital reserve transfers [4][5]. 3. Commitments Related to Restricted Shares - The shareholders of the restricted shares have committed not to transfer or manage their shares for three years post-IPO. They can only reduce their holdings by a maximum of 2% of the total shares in the fourth and fifth fiscal years after the IPO [5][10]. 4. Verification of Commitments - As of the date of the verification opinion, the shareholders have strictly adhered to their commitments, and there are no issues affecting the listing of the restricted shares [6][10]. 5. Details of Restricted Shares - The total number of restricted shares to be listed is 34,032,240, which constitutes 8.48% of the total share capital. The listing date for these shares is set for July 7, 2025 [6][8][10].

证券代码：688322 证券简称：奥比中光 公告编号：2025-056 奥比中光科技集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 本次股票上市流通总数为34,032,240股。 ? 本次股票上市流通日期为2025 年 7 月 7 日。 本次申请解除股份限售的相关股东除需要遵守已做出的关于所持奥比中光科 技集团股份有限公司（以下简称"公司"）股份锁定、减持等相关承诺外，还应 当遵守《上市公司股东减持股份管理暂行办法》《上海证券交易所上市公司自律 监管指引第 15 号——股东及董事、高级管理人员减持股份》等法规及规范性文 件中关于股份减持的相关规定。根据前述规定，截至本公告出具日，在公司最近 三个已披露经审计的年度报告的会计年度因亏损而现金分红不达标的情况下，本 次申请解除股份限售的 6 名股东均不得通过证券交易所集中竞价交易或者大宗交 易方式减持公司股份。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会（以下简称 ...

证券代码：688322 证券简称：奥比中光 公告编号：2025-056 奥比中光科技集团股份有限公司 首次公开发行部分限售股上市流通的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 34,032,240股。 本次股票上市流通总数为34,032,240股。 本次股票上市流通日期为2025 年 7 月 7 日。 本次申请解除股份限售的相关股东除需要遵守已做出的关于所持奥比中光科 技集团股份有限公司（以下简称"公司"）股份锁定、减持等相关承诺外，还应 当遵守《上市公司股东减持股份管理暂行办法》《上海证券交易所上市公司自律 监管指引第 15 号——股东及董事、高级管理人员减持股份》等法规及规范性文 件中关于股份减持的相关规定。根据前述规定，截至本公告出具日，在公司最近 三个已披露经审计的年度报告的会计年度因亏损而现金分红不达标的情况下，本 次申请解除股份限售的 6 名股东均不得通过证券交易所集中竞价交易或者大宗交 易方式减持公司股份。 一、 ...

中国国际金融股份有限公司 关于奥比中光科技集团股份有限公司 首次公开发行部分限售股上市流通的核查意见 中国国际金融股份有限公司（以下简称"中金公司"或"保荐机构"）作为承接奥 比中光科技集团股份有限公司（以下简称"奥比中光"、"公司"或"发行人"）首次 公开发行股票并在科创板上市持续督导工作的保荐机构，根据《中华人民共和国公司法》 《中华人民共和国证券法》《证券发行上市保荐业务管理办法》《上海证券交易所科创 板股票上市规则》及《科创板上市公司持续监管办法（试行）》等有关法律法规和规范 性文件的要求，对奥比中光首次公开发行部分限售股上市流通事项进行了审慎核查，具 体核查情况及核查意见如下： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2022 年 4 月 22 日出具 的《关于同意奥比中光科技集团股份有限公司首次公开发行股票注册的批复》（证监许 可〔2022〕849 号），同意奥比中光首次公开发行股票的注册申请。公司首次向社会公 众公开发行人民币普通股（A 股）股票 40,001,000 股，并于 2022 年 7 月 7 日在上海证 券交易所科创板上市，发行完成后总股 ...

Core Viewpoint - The current era is considered the best time for technological advancements, particularly in robotics and AI, according to the CEO of Orbbec Technology, Huang Yuanhao [2]. Company Overview - Orbbec Technology, founded in 2013, is headquartered in Shenzhen and was listed on the STAR Market in July 2022. The company specializes in high-performance 3D vision sensors and AI vision solutions for various industries, including robotics and biometric recognition [1]. - The company has invested nearly 1 billion RMB in R&D over the past three years, indicating a strong commitment to innovation [2]. Financial Performance - Orbbec Technology is experiencing rapid growth, with a projected revenue increase of 56% in 2024 and a remarkable 117% growth from January to May this year. The company aims to surpass 1 billion RMB in revenue this year, marking its first profitable year since going public [2]. Market Position - Orbbec Technology holds over 70% market share in the Chinese service robot 3D vision sensor sector, making it a leader in the global 3D vision market [3]. - The company is one of the few in the market capable of providing a complete set of proprietary 3D vision perception products and has a comprehensive layout across six major 3D vision technology routes [3]. Technological Innovation - The future of robotic vision is expected to shift towards highly integrated systems that are compact, low-power, and high-performance, moving away from traditional large and independent components [3]. - The company believes that through continuous technological innovation and scene optimization, robotic vision technology will evolve to surpass human visual capabilities [4].

Group 1 - A total of 30 companies were investigated by institutions on June 24, with 17 companies specifically targeted by funds [1][2] - The most popular company among funds was Steady Medical, which had 37 participating funds, followed by Obsidian Technology with 20 funds and Tianshan Electronics with 10 funds [1][2] - The companies investigated belong to 12 different industries, with the electronics and computer sectors having the highest representation, each with 3 stocks [1] Group 2 - Among the companies investigated, 9 had a total market capitalization of less than 10 billion yuan, including Aoya Co., Ltd., Weili Transmission, and Pengyao Environmental Protection [1] - In terms of market performance, 11 stocks among the investigated companies saw an increase in the last 5 days, with Tianshan Electronics, Obsidian Technology, and Honghua Digital Science leading with gains of 25.51%, 14.21%, and 6.00% respectively [1][2] - Conversely, 6 stocks experienced declines, with Mankalon, Aoya Co., Ltd., and Steady Medical showing the largest drops of 10.37%, 8.56%, and 6.61% respectively [1][2] Group 3 - In terms of net capital inflow over the last 5 days, 7 stocks saw positive inflows, with Obsidian Technology attracting the most at 105 million yuan, followed by Haixia Co., Ltd. and Robotech with inflows of 27.48 million yuan and 14.63 million yuan respectively [2]